The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief
NCT ID: NCT05178589
Last Updated: 2023-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2022-03-01
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study
NCT00229164
Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea
NCT06741059
The Effectivenes of Non-invasive Neuromodulation in Adult Women With Primary Dysmenorrhea, Through the TENS Stimulation at Different Times of Mentrual Cycle in Each Group
NCT06233786
TENS for Endometriosis Pain in Adolescents and Young Adults
NCT06914752
Application of Electrical Neurostimulation Transcutaneous in Patients With Primary Dysmenorrhea.
NCT02205970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
During the control condition cycle (no TENS), participants will refrain from using or taking other analgesics, besides ibuprofen.
No interventions assigned to this group
One Unit TENS
Participants will use one-unit TENS set-up where the TENS unit has 2 channels.
One Unit TENS
TENS was administered by the participant at home. Application was limited to the abdominal area and instructed to be placed at the location of pain. Single unit TENS was administered via 2 channels. Participants chose an intensity of comfort and continued the treatment for 30-90 minutes per session with unlimited sessions allowed per day.
Two Unit TENS
Participants will use a two-unit TENS set-up where the TENS unit has 4 channels.
Two Unit TENS
TENS was administered by the participant at home. Application was limited to the abdominal area and instructed to be placed at the location of pain. Double unit TENS was administered via 4 channels. Participants chose an intensity of comfort and continued the treatment for 30-90 minutes per session with unlimited sessions allowed per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
One Unit TENS
TENS was administered by the participant at home. Application was limited to the abdominal area and instructed to be placed at the location of pain. Single unit TENS was administered via 2 channels. Participants chose an intensity of comfort and continued the treatment for 30-90 minutes per session with unlimited sessions allowed per day.
Two Unit TENS
TENS was administered by the participant at home. Application was limited to the abdominal area and instructed to be placed at the location of pain. Double unit TENS was administered via 4 channels. Participants chose an intensity of comfort and continued the treatment for 30-90 minutes per session with unlimited sessions allowed per day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI of 18.5-29.9 as a BMI below or above these cut points results in highly varied menstrual cycle lengths
* Not taking contraception or other types of medication that could influence reproductive status
* Regular menstruation
* Medically free from chronic diseases
* Free from known gynecological problems (ie. Endometriosis, Fibroids, Ovarian Cysts)
* History of analgesic pill intake during menstruation
* No pelvic pathology
Exclusion Criteria
* On a form of contraception
* Secondary dysmenorrhea and/or other gynecological problems that may cause pain
* No discomfort, pain, or other symptoms during menstruation
* History of surgery over lower abdomen area
* Allergy to ibuprofen
* Cardiac disability
* Pacemaker
* Arterial disease
* Uncontrolled hemorrhage
* Blood clots
* Pregnancy or trying to become pregnant
* Cancerous lesions
* Exposed metal implants
* History of seizures
* Sensory or mental impairment
* Unstable fractures
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Todd Schroeder
Associate Professor of Clinical Physical Therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Todd Schroeder, PhD
Role: PRINCIPAL_INVESTIGATOR
Associated Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern California Health Sciences Campus Center for Health Professions
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McLagan B, Dexheimer J, Strock N, Goldstein S, Guzman S, Erceg D, Schroeder ET. The role of transcutaneous electrical nerve stimulation for menstrual pain relief: A randomized control trial. Womens Health (Lond). 2024 Jan-Dec;20:17455057241266455. doi: 10.1177/17455057241266455.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-21-00629
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.